7-methoxy-8-(3-methylpent-2-enyl)coumarin, osthol, osthole

| Name | Osthol | ||
| PubChem CID | 10228 | ||
| Molecular Weight | 244.28g/mol | ||
| Synonyms |
7-methoxy-8-(3-methylpent-2-enyl)coumarin, osthol, osthole |
||
| Formula | C₁₅H₁₆O₃ | ||
| SMILES | CC(=CCC1=C(C=CC2=C1OC(=O)C=C2)OC)C | ||
| InChI | 1S/C15H16O3/c1-10(2)4-7-12-13(17-3)8-5-11-6-9-14(16)18-15(11)12/h4-6,8-9H,7H2,1-3H3 | ||
| InChIKey | MBRLOUHOWLUMFF-UHFFFAOYSA-N | ||
| CAS Number | 484-12-8 | ||
| ChEMBL ID | CHEMBL52229 | ||
| ChEBI ID | CHEBI:69832 | ||
| Herb ID | HBIN038387 | ||
| KEGG ID | C09280 | ||
| Toxicity | Organism | Test Type | Route(Dose) |
| rat | LD50 | intraperitoneal(165 mg/kg) | |
| mouse | LD50 | intraperitoneal(254 mg/kg) | |
| rat | LD50 | oral(322 mg/kg) | |
| Structure |
Download
2D
MOL
3D
MOL
|
||
| Chineses Pinyin | CangZhu | ||
| Use Part | Rhizome | ||
| Habitat | HeNan, ShanDong | ||
| Flavor | Pungent, Bitter | ||
| Meridian Tropism | Spleen, Stomach, Liver | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Asterales
-->Family: Asteraceae
-->Genus: Atractylodes
-->Species: Atractylodes lancea
|
||
| Chineses Pinyin | DuHuo | ||
| Use Part | Root | ||
| Habitat | HuBei, SiChuan, JiangXi | ||
| Flavor | Pungent; Bitter | ||
| Meridian Tropism | Kidney; Bladder | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Apiaceae
-->Genus: Angelica
-->Species: Angelica pubescens
|
||
| Pair Name | Osthol, Lobaplatin | |||
| Partner Name | Lobaplatin | |||
| Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Up-regulation | Expression | TP53 | hsa7157 |
| Down-regulation | Expression | BCL2 | hsa596 | |
| Up-regulation | Expression | BAX | hsa581 | |
| Up-regulation | Expression | CASP3 | hsa836 | |
| In Vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 |
| Result | OST enhanced the apoptosis-mediated growth inhibitory effect of lobaplatin on breast cancer cells and has potential for the treatment of breast cancer in the future. | |||
| Pair Name | Osthol, Temozolomide | |||
| Partner Name | Temozolomide | |||
| Disease Info | [ICD-11: 2A00] | Glioblastoma multiforme | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
| Up-regulation | Expression | CASP3 | hsa836 | |
| Down-regulation | Expression | BECN1 | hsa8678 | |
| In Vitro Model | T98G | Glioblastoma | Homo sapiens (Human) | CVCL_0556 |
| MOG-G-CCM | Anaplastic astrocytoma | Homo sapiens (Human) | CVCL_2613 | |
| Result | Our results indicated that osthole effectively eliminated glioma cells via apoptosis, what was correlated with Bcl-2/Beclin 1 complex formation. Considering the anti-migratory effect, osthole and Temozolomide display antiglioma potential but it needs further extensive studies. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells. Med Oncol. 2021 Nov 27;39(1):16. doi: 10.1007/s12032-021-01609-4. | Click |
| 2 | Coumarins modulate the anti-glioma properties of temozolomide. Eur J Pharmacol. 2020 Aug 15;881:173207. doi: 10.1016/j.ejphar.2020.173207. | Click |